78277602 - LIPOSTABIL

Information

  • Trademark
  • 78277602
  • Serial Number
    78277602
  • Registration Number
    2912914
  • Filing Date
    July 23, 2003
    21 years ago
  • Registration Date
    December 21, 2004
    19 years ago
  • Transaction Date
    August 30, 2011
    13 years ago
  • Status Date
    July 22, 2011
    13 years ago
  • Published for Opposition Date
    September 28, 2004
    20 years ago
  • Location Date
    December 21, 2004
    19 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    OSBORNE, STANLEY I
  • Attorney Name
    Margaret H. Bitler
    Law Office Assigned Location Code
    L20
  • Owners
Mark Drawing Code
1000
Mark Identification
LIPOSTABIL
Case File Statements
  • GS0051: pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues
  • GS0441: providing a website on global computer networks featuring information on pharmaceutical preparations in the fields of pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use in the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respirattory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, for use n the gastroenterological area, and the prevention and treatment of ocular disorders or diseases; and pharmaceuticals for the treatment of weight and fat reduction issues
Case File Event Statements
  • 7/22/2011 - 13 years ago
    14 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 8/17/2005 - 19 years ago
    13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/21/2004 - 19 years ago
    12 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/28/2004 - 20 years ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/8/2004 - 20 years ago
    10 - NOTICE OF PUBLICATION Type: NPUB
  • 7/19/2004 - 20 years ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/13/2004 - 20 years ago
    8 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 6/30/2004 - 20 years ago
    7 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 6/30/2004 - 20 years ago
    6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/30/2004 - 20 years ago
    5 - PAPER RECEIVED Type: MAIL
  • 6/9/2004 - 20 years ago
    4 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/9/2004 - 20 years ago
    3 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/20/2003 - 20 years ago
    2 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/15/2003 - 20 years ago
    1 - ASSIGNED TO EXAMINER Type: DOCK